Evidence map›Paper›PMID 22340449›Full record

ArticleInternational journal of clinical practice2012

Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain.

M Mata-Cases, P Roura-Olmeda, M Berengué-Iglesias, M Birulés-Pons, X Mundet-Tuduri, J Franch-Nadal, B Benito-Badorrey, J F Cano-Pérez, Diabetes Study Group in Primary Health Care (GEDAPS: Grup d’Estudi de la Diabetis a l’Atenció Primària de Salut, Catalonian Society of Family and Community Medicine)

Open access · bronzeAbstract read
In one paragraph

Article in International journal of clinical practice, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Type 2 diabetes and quality of life.World journal of diabetes · 2017
    Review
  11. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.The European journal of health economics : HEPAC : health economics in prevention and care · 2016
    Article
  12. Observational
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

M Mata-CasesPrimary Care Center (PCC) La Mina, Sant Adrià de Besòs, Barcelona, Spain. manelmatacases@gmail.com
P Roura-Olmeda
M Berengué-Iglesias
M Birulés-Pons
X Mundet-Tuduri
J Franch-Nadal
B Benito-Badorrey
J F Cano-Pérez
Diabetes Study Group in Primary Health Care (GEDAPS: Grup d’Estudi de la Diabetis a l’Atenció Primària de Salut, Catalonian Society of Family and Community Medicine)
Red de Investigación en Actividades Preventivas y Promoción de la Salud · ESAjuntament de L’Hospitalet · ESHospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo assess the evolution of type 2 diabetes mellitus (T2DM) quality indicators in primary care centers (PCC) as part of the Group for the Study of Diabetes in Primary Care (GEDAPS) Continuous Quality Improvement (GCQI) programme in Catalonia.

methodsSequential cross-sectional studies were performed during 1993-2007. Process and outcome indicators in random samples of patients from each centre were collected. The results of each evaluation were returned to each centre to encourage the implementation of correcting interventions. Sixty-four different educational activities were performed during the study period with the participation of 2041 professionals.

resultsClinical records of 23,501 patients were evaluated. A significant improvement was observed in the determination of some annual process indicators: HbA(1c) (51.7% vs. 88.9%); total cholesterol (75.9% vs. 90.9%); albuminuria screening (33.9% vs. 59.4%) and foot examination (48.9% vs. 64.2%). The intermediate outcome indicators also showed significant improvements: glycemic control [HbA(1c) ≤ 7% (< 57 mmol/mol); (41.5% vs. 64.2%)]; total cholesterol [≤ 200 mg/dl (5.17 mmol/l); (25.5% vs. 65.6%)]; blood pressure [≤ 140/90 mmHg; (45.4% vs. 66.1%)]. In addition, a significant improvement in some final outcome indicators such as prevalence of foot ulcers (7.6% vs. 2.6%); amputations (1.9% vs. 0.6%) and retinopathy (18.8% vs. 8.6%) was observed.

conclusionsAlthough those changes should not be strictly attributed to the GCQI programme, significant improvements in some process indicators, parameters of control and complications were observed in a network of primary care centres in Catalonia.

Indexed as

Quality of Health CareAdultAgedAged, 80 and overBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansMaleMiddle AgedPrimary Health CareSpainBlood GlucoseGlycated Hemoglobin

Identifiers

PMID22340449
PMCPMC3584513
OpenAlexW1491822651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.